The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy

PLoS One. 2020 Aug 13;15(8):e0234492. doi: 10.1371/journal.pone.0234492. eCollection 2020.

Abstract

Endothelial injury is a common manifestation in IgA nephropathy (IgAN). After the previous identification of the upregulated soluble fms-like tyrosine kinase-1 (sFlt-1) correlated with endothelial injury in IgAN, in the present study, we further explored the role of sFlt-1 in endothelial injury in IgAN. We enrolled 72 patients with IgAN and detected the sFlt-1 levels. The polymeric IgA1 (pIgA1) complexes were isolated from the pooled plasma samples of another 10 patients with IgAN. Apoptosis proteins were detected in cultured human umbilical vein endothelial cells (HUVECs) with the stimulation of recombinant sFlt-1 or the caspase-9 inhibitor Z-LEHD-FMK. We identified there were positive correlations between sFlt-1 and IgA-IgG complex as well as vWF levels in patients with IgAN. The sFlt-1 levels in HUVECs were significantly upregulated by pIgA1 complex derived from IgAN patients in a concentration-dependent manner. The proliferation ability of HUVECs was damaged when stimulated with sFlt-1 protein in a time- and dose- dependent manner. And the apoptosis rate was up-regulated significantly as the stimulation concentrations of sFlt-1 increased. We found sFlt-1 challenge could significantly increase the expression of vWF. In addition, sFlt-1 increased the levels of caspase-9, caspase-3, Bax and mitochondrial membrane potential; facilitated the release of cytochrome C from mitochondria to cytoplasma. In contrast, Z-LEHD-FMK attenuated high sFlt-1-induced HUVECs apoptosis. In conclusion, our study demonstrated that sFlt-1 expression was up-regulated by the challenge of pIgA1 complex derived from patients with IgAN. Furthermore, increased sFlt-1 facilitated human umbilical vein endothelial cells apoptosis via the mitochondrial-dependent pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Apoptosis Regulatory Proteins / physiology
  • Caspase 9 / drug effects
  • Caspase Inhibitors / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology*
  • Female
  • Glomerulonephritis, IGA / blood
  • Glomerulonephritis, IGA / pathology
  • Glomerulonephritis, IGA / physiopathology*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Mitochondria / drug effects
  • Mitochondria / physiology
  • Oligopeptides / pharmacology
  • Vascular Endothelial Growth Factor Receptor-1 / blood
  • Vascular Endothelial Growth Factor Receptor-1 / physiology*
  • Young Adult

Substances

  • Apoptosis Regulatory Proteins
  • Caspase Inhibitors
  • Immunoglobulin A
  • Immunoglobulin G
  • Oligopeptides
  • benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone
  • polymeric IgA
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • CASP9 protein, human
  • Caspase 9

Grants and funding

The work was supported by the National Natural Science Foundation for young scientists of China (Grant No. 81600555 and 81600552, 81900643) and the National Science Foundation for Post-doctoral scientists of China (Grant No.2018M640684 and 2019M652592), as well as the National Natural Science Foundation of China (Grant Nos. 81873611), Science and Technology Innovation Team of Henan (Grant No. 17IRTSTHN020); Foundation for Leading Personnel of Central Plains of China (Grant No. 194200510006).